Security key
88338N206
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)
CUSIP: 88338N206
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 3,408,566
- Total 13F value
- $5,487,879
- Share change
- +31,516
- Put/Call ratio
- 1.1%
- SEC-reported price per share
- $1.61
- Number of holders
- 34
- Value change
- -$167
- Number of buys
- 8
- Number of sells
- 19
- Shares outstanding
- 11,676,558
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
34
Top holders
10
TXMD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88338N206
Recent filing periods:
Ownership snapshot
Top reported holders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Rubric Capital Management LP
Disclosed value leader
Rubric Capital Management LP
Comparable rows
15/15
Latest evidence
31 Mar 2024
3/4/5
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
Rubric Capital Management LP leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Rubric Capital Management LP's linked filing trail.
Comparable ownership
Top 5
Rubric Capital Management LP
10%
Clearline Capital LP
4.6%
Tejara Capital Ltd
3.4%
VANGUARD GROUP INC
3.3%
ADAR1 Capital Management, LLC
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Rubric Capital Management LP |
3/4/5
13F
Director, Other*, 10%+ Owner · Company
|
10%
from 13F
|
$6,718,950
2,946,908 shares
|
— | 15 Nov 2023 |
| Clearline Capital LP |
13F
Company
|
4.6%
|
$1,225,929
535,340 shares
|
— | 31 Mar 2024 |
| Tejara Capital Ltd |
13F
Company
|
3.4%
|
$920,436
401,937 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
3.3%
|
$887,563
387,582 shares
|
— | 31 Mar 2024 |
| ADAR1 Capital Management, LLC |
13F
Company
|
2.3%
|
$623,246
272,160 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
1.2%
|
$310,934
135,779 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
34
Shares
3,408,566
Rows available
34
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
43
Q2 2024 holders
34
Holder diff
-9
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend